Class IIReported 2025-02-05

Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01

Recalled by McKesson

Reason for Recall

cGMP Deviations: Product intended for quarantine was inadvertently distributed.

Recall Number

D-0213-2025

Classification

Class II

Status

Ongoing